Pulmonary Hypertension (PH)
Causes (WHO classification)
1. Pulmonary arterial hypertension (PAH)
o Idiopathic, connective tissue diseases (e.g., systemic sclerosis), HIV, portal hypertension
2. Left heart disease
o LV dysfunction, mitral/aortic valve disease
3. Lung diseases and hypoxia
o COPD, ILD, OSA
4. Chronic thromboembolic pulmonary hypertension (CTEPH)
5. Miscellaneous (e.g., sarcoidosis)
Clinical features
• Dyspnoea, fatigue, syncope
• Loud P2, right ventricular heave
• Tricuspid regurgitation murmur, raised JVP
Investigations
• Echo: RV dilatation, elevated pulmonary pressures
• Right heart catheterisation: gold standard for diagnosis
Treatment
• Underlying cause
• PAH-specific: endothelin receptor antagonists (bosentan), PDE-5 inhibitors (sildenafil), prostacyclin analogues
Pulmonary Embolism (PE)
Clinical presentation
• Sudden-onset dyspnoea, pleuritic chest pain, haemoptysis
• Tachycardia, hypoxia, possible hypotension if massive
Diagnosis
• Wells score (clinical probability)
• D-dimer (if low-intermediate probability)
• CT pulmonary angiogram (CTPA): gold standard
Treatment
• LMWH (first-line)
• DOACs (e.g., apixaban, rivaroxaban) or warfarin after initial anticoagulation
• Thrombolysis if massive PE with haemodynamic instability
Deep Vein Thrombosis (DVT)
Risk factors
• Virchow's triad: stasis (immobility), hypercoagulability (malignancy, OCP, thrombophilia), endothelial injury (surgery)
Clinical features
• Unilateral leg swelling, pain, warmth
Diagnosis
• Wells score
• Proximal leg vein ultrasound (first-line)
Treatment
• Anticoagulation (as for PE)
• Compression stockings after resolution to prevent post-thrombotic syndrome
Systemic Hypertension
Classification
• Essential (90–95%)
• Secondary
o Renal artery stenosis (young, flash pulmonary oedema)
o Primary hyperaldosteronism (Conn’s): hypertension + hypokalaemia
o Phaeochromocytoma: paroxysmal HTN, headache, palpitations, sweating
o Cushing’s syndrome, thyroid disorders
Targets
• <140/90 mmHg (clinic)
• <130/80 mmHg if CKD, diabetes, or target organ damage
First-line treatment
• <55 years or diabetic: ACE inhibitor
• 55 or Afro-Caribbean: CCB
Aortic Dissection
Presentation
• Sudden, severe tearing chest/back pain
• Pulse deficits, asymmetrical BP
• New aortic regurgitation murmur
Classification
• Stanford A: ascending ± descending → surgical emergency
• Stanford B: descending only → medical therapy unless complications
Diagnosis
• CT angiogram (gold standard)
• CXR: widened mediastinum
Treatment
• Control BP (IV labetalol), pain control
• Surgery for type A
Peripheral Arterial Disease (PAD)
Features
• Intermittent claudication (pain on exertion, relieved by rest)
• Critical limb ischaemia: rest pain, ulcers, gangrene
• Reduced/absent pulses
Diagnosis
• Ankle–brachial index (ABI):
o <0.9 diagnostic of PAD
o <0.5 indicates severe ischaemia
Management
• Smoking cessation
• Antiplatelet therapy, statin
• Supervised exercise program
• Revascularisation (angioplasty/bypass) if severe
Carotid Artery Disease
Risk
• TIA or stroke from emboli
Intervention
• Carotid endarterectomy:
o Symptomatic stenosis ≥70% (NASCET criteria)
o Consider 50–69% if high risk
Extra Revision Pearls
• Loud P2 clue → PH (esp. in young with CTD)
• RV heave clue → chronic cor pulmonale, PH
• Stanford A clue → surgery always; can cause tamponade, AR
• ABI <0.5 clue → limb-threatening ischaemia
• Conn’s clue → HTN + low K⁺; high aldosterone, low renin
• Phaeochromocytoma clue → episodic triad + 24h urinary metanephrines
• Hypertensive urgency vs emergency → end-organ damage defines emergency